1. Home
  2. AX vs ACAD Comparison

AX vs ACAD Comparison

Compare AX & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axos Financial Inc.

AX

Axos Financial Inc.

HOLD

Current Price

$92.07

Market Cap

4.8B

Sector

Finance

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$25.68

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AX
ACAD
Founded
1999
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.4B
IPO Year
2005
2004

Fundamental Metrics

Financial Performance
Metric
AX
ACAD
Price
$92.07
$25.68
Analyst Decision
Strong Buy
Buy
Analyst Count
7
22
Target Price
$97.07
$30.00
AVG Volume (30 Days)
329.6K
1.2M
Earning Date
01-29-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.53
EPS
7.44
1.54
Revenue
$1,202,571,000.00
$1,047,118,000.00
Revenue This Year
$17.20
$15.16
Revenue Next Year
$9.57
$11.79
P/E Ratio
$12.43
$17.00
Revenue Growth
6.69
12.69
52 Week Low
$54.46
$13.40
52 Week High
$99.82
$28.35

Technical Indicators

Market Signals
Indicator
AX
ACAD
Relative Strength Index (RSI) 54.16 43.17
Support Level $91.01 $25.25
Resistance Level $94.05 $27.22
Average True Range (ATR) 2.66 0.95
MACD -0.32 -0.13
Stochastic Oscillator 20.03 18.16

Price Performance

Historical Comparison
AX
ACAD

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: